{
  "cik": 2035832,
  "cik_padded": "0002035832",
  "entityName": "Aktis Oncology, Inc.",
  "fiscal_years": [],
  "latest_filing": {
    "accn": "0001193125-26-131748",
    "filed": "2026-03-30",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0002035832.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0002035832.json"
  },
  "ticker": "AKTS"
}